Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies

Endpoints for Clinical Trials in Primary Hyperoxaluria

(2020) Dawn S. Milliner et al.   Clinical Journal of the American Society of Nephrology

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort

(2020) Ronak Jagdeep Shah et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function

(2020) Philip Hillebrand et al.   PEDIATRIC NEPHROLOGY

Plasma oxalate: comparison of methodologies

(2020) Felicity Stokes et al.   Urolithiasis

From pathogenesis to novel therapies in primary hyperoxaluria

(2019) Gill Rumsby et al.   Expert Opinion on Orphan Drugs

Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria

(2018) Sonia Fargue et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

(2017) Dawn Milliner et al.   Urolithiasis

Oxalate, inflammasome, and progression of kidney disease

(2016) Theresa Ermer et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

(2016) Bernd Hoppe et al.   PEDIATRIC NEPHROLOGY

Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria

(2015) K. Hopp et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oxalate: From the Environment to Kidney Stones

(2014) Hrvoje Brzica et al.   Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology

Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type

(2014) Giorgia Mandrile et al.   KIDNEY INTERNATIONAL

Primary Hyperoxaluria

(2013) Pierre Cochat et al.   NEW ENGLAND JOURNAL OF MEDICINE

Update on Oxalate Crystal Disease

(2013) Elizabeth C. Lorenz et al.   Current Rheumatology Reports

A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion

(2013) Marguerite Hatch et al.   Urolithiasis

Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions

(2012) Bodo B Beck et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

An update on primary hyperoxaluria

(2012) Bernd Hoppe   Nature Reviews Nephrology

Factors Related to Colonization with Oxalobacter formigenes in U.S. Adults

(2011) Judith Parsells Kelly et al.   JOURNAL OF ENDOUROLOGY

Net Intestinal Transport of Oxalate Reflects Passive Absorption and SLC26A6-mediated Secretion

(2011) F. Knauf et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria

(2011) B. Hoppe et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

New Equations to Estimate GFR in Children with CKD

(2009) G. J. Schwartz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

(2009) Jérôme Harambat et al.   KIDNEY INTERNATIONAL